Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin(BC Cancer Agency), Nathalie A. Johnson(BC Cancer Agency), Tesa Severson(BC Cancer Agency), Andrew J. Mungall(BC Cancer Agency), Jianghong An(BC Cancer Agency), Rodrigo Goya(BC Cancer Agency), Jessica E. Paul(BC Cancer Agency), Merrill Boyle(BC Cancer Agency), Bruce W. Woolcock(BC Cancer Agency), Florian Kuchenbauer(BC Cancer Agency), Damian Yap(BC Cancer Agency), R. Keith Humphries(BC Cancer Agency), Obi L. Griffith(BC Cancer Agency), Sohrab P. Shah(BC Cancer Agency), Henry Zhu(BPS Bioscience (United States)), Michelle Kimbara(BPS Bioscience (United States)), Pavel Shashkin(BPS Bioscience (United States)), Jean Charlot(BPS Bioscience (United States)), Marianna Tcherpakov(BPS Bioscience (United States)), Richard Corbett(BC Cancer Agency), Angela Tam(BC Cancer Agency), Richard Varhol(BC Cancer Agency), Duane E. Smailus(BC Cancer Agency), Michelle Moksa(BC Cancer Agency), Yongjun Zhao(BC Cancer Agency), Allen Delaney(BC Cancer Agency), Hong Qian(BC Cancer Agency), İnanç Birol(BC Cancer Agency), Jacqueline E. Schein(BC Cancer Agency), Richard A. Moore(BC Cancer Agency), Robert A. Holt(BC Cancer Agency), Doug Horsman(University of British Columbia), Joseph M. Connors(BC Cancer Agency), Steven J.M. Jones(BC Cancer Agency), Samuel Aparício(BC Cancer Agency), Martin Hirst(BC Cancer Agency), Randy D. Gascoyne(University of British Columbia), Marco A. Marra(BC Cancer Agency)
Cited by 1,649Open Access